Low-dose Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibition of EGFR Mutation-positive Lung Cancer: Therapeutic Benefits and Associations Between Dosage, Efficacy and Body Surface Area

Saved in:
Bibliographic Details
Published inAsian Pacific journal of cancer prevention : APJCP Vol. 17; no. 2; pp. 785 - 789
Main Authors Hirano, Ryosuke, Uchino, Junji, Ueno, Miho, Fujita, Masaki, Watanabe, Kentaro
Format Journal Article
LanguageEnglish
Published 07.03.2016
Online AccessGet full text

Cover

More Information
ISSN:1513-7368
DOI:10.7314/APJCP.2016.17.2.785